Your browser doesn't support javascript.
loading
E-cadherin breast tumor expression, risk factors and survival: Pooled analysis of 5,933 cases from 12 studies in the Breast Cancer Association Consortium.
Horne, Hisani N; Oh, Hannah; Sherman, Mark E; Palakal, Maya; Hewitt, Stephen M; Schmidt, Marjanka K; Milne, Roger L; Hardisson, David; Benitez, Javier; Blomqvist, Carl; Bolla, Manjeet K; Brenner, Hermann; Chang-Claude, Jenny; Cora, Renata; Couch, Fergus J; Cuk, Katarina; Devilee, Peter; Easton, Douglas F; Eccles, Diana M; Eilber, Ursula; Hartikainen, Jaana M; Heikkilä, Päivi; Holleczek, Bernd; Hooning, Maartje J; Jones, Michael; Keeman, Renske; Mannermaa, Arto; Martens, John W M; Muranen, Taru A; Nevanlinna, Heli; Olson, Janet E; Orr, Nick; Perez, Jose I A; Pharoah, Paul D P; Ruddy, Kathryn J; Saum, Kai-Uwe; Schoemaker, Minouk J; Seynaeve, Caroline; Sironen, Reijo; Smit, Vincent T H B M; Swerdlow, Anthony J; Tengström, Maria; Thomas, Abigail S; Timmermans, A Mieke; Tollenaar, Rob A E M; Troester, Melissa A; van Asperen, Christi J; van Deurzen, Carolien H M; Van Leeuwen, Flora F; Van't Veer, Laura J.
Affiliation
  • Horne HN; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
  • Oh H; Division of Molecular Genetics & Pathology, US Food and Drug Administration, Silver Spring, MD, USA.
  • Sherman ME; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
  • Palakal M; Department of Health Policy and Management, College of Health Science, Korea University, Seoul, Korea.
  • Hewitt SM; Health Sciences Research, Mayo Clinic, Jacksonville, FL, USA.
  • Schmidt MK; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
  • Milne RL; Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
  • Hardisson D; Division of Molecular Pathology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
  • Benitez J; Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek hospital, Amsterdam, The Netherlands.
  • Blomqvist C; Cancer Epidemiology & Intelligence Division, Cancer Council Victoria, Melbourne, Victoria, Australia.
  • Bolla MK; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global health, The University of Melbourne, Melbourne, Victoria, Australia.
  • Brenner H; Department of Pathology, Molecular Pathology and Therapeutic Targets Group, Hospital Universitario La Paz IdiPAZ, and Facultad de Medicina, Universidad Autonoma de Madrid, Madrid, Spain.
  • Chang-Claude J; Human Cancer Genetics Program, Spanish National Cancer Research Centre, Madrid, Spain.
  • Cora R; Centro de Investigación en Red de Enfermedades Raras (CIBERER), Valencia, Spain.
  • Couch FJ; Department of Oncology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
  • Cuk K; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Devilee P; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Easton DF; Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany.
  • Eccles DM; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Eilber U; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Hartikainen JM; Research Group Genetic Cancer Epidemiology, University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Heikkilä P; Independent contractor, CT(ASCP), MB (ASCP), National Cancer Institute, Bethesda, MD, USA.
  • Holleczek B; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
  • Hooning MJ; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Jones M; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
  • Keeman R; Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.
  • Mannermaa A; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Martens JWM; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
  • Muranen TA; Cancer Sciences Academic Unit, Faculty of Medicine, University of Southampton, Southampton, UK.
  • Nevanlinna H; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Olson JE; Translational Cancer Research Area, University of Eastern Finland, Kuopio, Finland.
  • Orr N; Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland.
  • Perez JIA; Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland.
  • Pharoah PDP; Department of Pathology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
  • Ruddy KJ; Saarland Cancer Registry, Saarbrücken, Germany.
  • Saum KU; Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Schoemaker MJ; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
  • Seynaeve C; Division of Molecular Pathology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
  • Sironen R; Translational Cancer Research Area, University of Eastern Finland, Kuopio, Finland.
  • Smit VTHBM; Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland.
  • Swerdlow AJ; Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland.
  • Tengström M; Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Thomas AS; Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
  • Timmermans AM; Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
  • Tollenaar RAEM; Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
  • Troester MA; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.
  • van Asperen CJ; Servicio de Cirugía General y Especialidades, Hospital Monte Naranco, Oviedo, Spain.
  • van Deurzen CHM; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Van Leeuwen FF; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
  • Van't Veer LJ; Department of Oncology, Mayo Clinic, Rochester, MN, USA.
Sci Rep ; 8(1): 6574, 2018 04 26.
Article in En | MEDLINE | ID: mdl-29700408
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Cadherins / Gene Expression Type of study: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: Sci Rep Year: 2018 Document type: Article Affiliation country: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Cadherins / Gene Expression Type of study: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: Sci Rep Year: 2018 Document type: Article Affiliation country: Estados Unidos